ABIL® Quat 3272 is used in conditioning shampoos and hair rinses. This product is substantive to the hair keratin. It improves comb ability of wet and dry hair, electrostatic charge is reduced and the hair becomes silky, shiny and manageable. ABIL® Quat 3272 is of high molecular weight and is well compatible with anionic surfactants. ABIL® Quat 3272 is preferred for use in shampoos, shower and bath preparations and liquid soaps. In skin cleansing preparations the interaction of ABIL® Quat 3272 with skin proteins provides a refatting effect that imparts a smooth and supple feel to cleansed skin.
| Name (CAS Number) | |
|---|---|
| Siloxanes and Silicones, dimethyl, 3-[3-[(3-coco amidopropyl)dimethylammonio]-2-hydroxypropoxy]propyl group-terminated, acetates (salts) (134737-05-6) | Sign in to view |
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
| Name (CAS Number) | |
|---|---|
|
Siloxanes and Silicones, dimethyl, 3-[3-[(3-coco amidopropyl)dimethylammonio]-2-hydroxypropoxy]propyl group-terminated, acetates (salts) (134737-05-6)
|
Sign in to view |
| General | |||
|---|---|---|---|
| Appearance | Sign in to view | ||
| Color | Sign in to view | ||
Evonik is a sustainable specialties partner to companies who develop and market products for beauty and personal care. Customers leverage our broad portfolio of ingredients, technologies and services to generate superior sustainability and functionality outcomes that can enable and enhance their formulations.
Evonik is a powerhouse and true global leader across a broad range of markets and applications: active ingredients, active delivery systems, skin care, sun care, color cosmetics, hair care and skin cleansing, alternative preservation and product stability.
We place sustainability at the center of everything we do, from sourcing, production and innovative processes to capital expenditure and M&A decisions.
UL hat diese Informationen vom Hersteller des Produktes übernommen. UL unternimmt umfangreiche Maßnahmen, um die Richtigkeit dieser Informationen sicherzustellen. Dennoch übernimmt UL keinerlei Verantwortung für diese Angaben und rät, nach der Materialauswahl die Angaben mit dem Hersteller direkt zu verifizieren.
Evonik – Personal Care stellt seine Produktinformationen in den unten aufgezeigten Regionen zur Verfügung:
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
With a Premium Prospector account, view regulatory advisory and retailer compliance on an ingredients level for your material searches. The full set of lists reviewed have been curated by UL's LOLI Regulatory Database specific for Prospector. Upgrade today!
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
Es tut uns leid. Die von Ihnen gewählte Industrie steht im Augenblick nicht in Ihrer Sprache zur Verfügung. Sie können gerne eine der unten angegebenen Sprachen auswählen, oder diesen Dialog schließen.
GDPR Notice: